基本信息
浏览量:21
职业迁徙
个人简介
Dr Ouyang has a multidisciplinary background in pharmaceutics & computer modelling, with experience in academia and industry. He obtained his bachelor (2000) and master (2005) in pharmaceutics from Shenyang Pharmaceutical University, China. He completed his PhD in pharmacy at The University of Queensland, Australia, in 2010 and progressed directly to his faculty position (Lecturer in Pharmaceutics, PI) at Aston University (UK). From the end of 2014, he moved to the University of Macau.
Since 2011, he has pioneered the integration of multi-scale modeling, artificial intelligence and big data techniques in the field of drug delivery – “computational pharmaceutics“. He has published 2 books, 5 book chapters and over 50 refereed SCI journal papers. He held 4 approved patents, which had been used in medicinal products. He edited the first book (John Wiley & Sons Inc., 2015) in this research area. He is invited to be the Editors-in-Chief of (Springer Nature) from January 2020. He also serves as the editorial board of and scientific advisor of . He is establishing the first global artificial intelligence (AI)-based formulation platform (www.computpharm.org). He successfully trained 4 PhD and 25 master. Currently his group includes 1 postdoctoral, 3 PhD students and 4 master students.
Since 2011, he has pioneered the integration of multi-scale modeling, artificial intelligence and big data techniques in the field of drug delivery – “computational pharmaceutics“. He has published 2 books, 5 book chapters and over 50 refereed SCI journal papers. He held 4 approved patents, which had been used in medicinal products. He edited the first book (John Wiley & Sons Inc., 2015) in this research area. He is invited to be the Editors-in-Chief of (Springer Nature) from January 2020. He also serves as the editorial board of and scientific advisor of . He is establishing the first global artificial intelligence (AI)-based formulation platform (www.computpharm.org). He successfully trained 4 PhD and 25 master. Currently his group includes 1 postdoctoral, 3 PhD students and 4 master students.
研究兴趣
论文共 142 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Xinyu Lou,Jinqiang Wang, Xiru Jin, Xu Wang,Bin Qin,Dongchun Liu,Xianbao Shi,Defang Ouyang,Zhonggui He,Jin Sun,Hongjun Li,Mengchi Sun
NANO TODAY (2024): 102091
Pharmaceutical researchno. 1 (2024): 63-75
JOURNAL OF CONTROLLED RELEASE (2024): 668-687
INNOVATIONno. 2 (2024): 100562-100562
Feiyan Gao,Zhongyi Ma,Xing Luo, Yahua Wang,Xinlong Liu,Mei Tang, Junyu Chen,Liangxing Tu,Defang Ouyang,Ji Zheng,Chong Li
Molecular pharmaceutics (2024)
Mingyang Liu,Ruizhe Zhang,Hanwei Huang,Pengfei Liu,Xu Zhao, Hu Wu,Ying He, Ruizhe Xu,Xifeng Qin,Zhenguo Cheng,Hongyu Liu,Onder Ergonul,
ADVANCED SCIENCEno. 5 (2024)
AAPS PharmSciTechno. 5 (2024): 1-16
AAPS PHARMSCITECHno. 5 (2024): 88-88
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn